Hinge Health, Inc. (NYSE: HNGE) Stock Competitors & Peer Comparison

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, VEEV has a market cap of 29.2B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while VEEV trades at $179.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas VEEV's P/E ratio is 21.57. In terms of profitability, HNGE's ROE is -1.39%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, HNGE is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check VEEV's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while GEHC trades at $61.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas GEHC's P/E ratio is 13.59. In terms of profitability, HNGE's ROE is -1.39%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, HNGE is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check GEHC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas GEHCV's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, HNGE is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check GEHCV's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, BTSG has a market cap of 13.7B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while BTSG trades at $69.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas BTSG's P/E ratio is 56.32. In terms of profitability, HNGE's ROE is -1.39%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check BTSG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, BTSGU has a market cap of 13.7B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while BTSGU trades at $230.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas BTSGU's P/E ratio is 207.29. In terms of profitability, HNGE's ROE is -1.39%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check BTSGU's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SGFY's P/E ratio is 70.91. In terms of profitability, HNGE's ROE is -1.39%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, HNGE is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SGFY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, TEM has a market cap of 8B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while TEM trades at $46.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas TEM's P/E ratio is -92.02. In terms of profitability, HNGE's ROE is -1.39%, compared to TEM's ROE of -0.70%. Regarding short-term risk, HNGE is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check TEM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, HQY has a market cap of 7.9B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while HQY trades at $94.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas HQY's P/E ratio is 22.04. In terms of profitability, HNGE's ROE is -1.39%, compared to HQY's ROE of +0.11%. Regarding short-term risk, HNGE is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check HQY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, TXG has a market cap of 6.1B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while TXG trades at $48.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas TXG's P/E ratio is -282.71. In terms of profitability, HNGE's ROE is -1.39%, compared to TXG's ROE of -0.03%. Regarding short-term risk, HNGE is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check TXG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas RCM's P/E ratio is -102.21. In terms of profitability, HNGE's ROE is -1.39%, compared to RCM's ROE of +0.00%. Regarding short-term risk, HNGE is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check RCM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, DOCS has a market cap of 3.8B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while DOCS trades at $20.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas DOCS's P/E ratio is 13.36. In terms of profitability, HNGE's ROE is -1.39%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, HNGE is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check DOCS's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas ONEM's P/E ratio is -7.77. In terms of profitability, HNGE's ROE is -1.39%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, HNGE is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ONEM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, PRVA has a market cap of 3.1B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while PRVA trades at $24.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas PRVA's P/E ratio is 156.06. In terms of profitability, HNGE's ROE is -1.39%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, HNGE is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check PRVA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, PGNY has a market cap of 2.4B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while PGNY trades at $30.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas PGNY's P/E ratio is 22.41. In terms of profitability, HNGE's ROE is -1.39%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, HNGE is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check PGNY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while HTFL trades at $24.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas HTFL's P/E ratio is -12.24. In terms of profitability, HNGE's ROE is -1.39%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, HNGE is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check HTFL's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while WGS trades at $63.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas WGS's P/E ratio is 74.56. In terms of profitability, HNGE's ROE is -1.39%, compared to WGS's ROE of -0.28%. Regarding short-term risk, HNGE is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check WGS's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas NXGN's P/E ratio is -266.00. In terms of profitability, HNGE's ROE is -1.39%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, HNGE is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check NXGN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while TDOC trades at $8.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas TDOC's P/E ratio is -9.62. In terms of profitability, HNGE's ROE is -1.39%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, HNGE is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check TDOC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas AGTI's P/E ratio is -71.79. In terms of profitability, HNGE's ROE is -1.39%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, HNGE is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check AGTI's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, OMDA has a market cap of 1.3B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while OMDA trades at $21.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas OMDA's P/E ratio is 302.86. In terms of profitability, HNGE's ROE is -1.39%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, HNGE is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check OMDA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CERT trades at $7.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CERT's P/E ratio is 18.23. In terms of profitability, HNGE's ROE is -1.39%, compared to CERT's ROE of -0.01%. Regarding short-term risk, HNGE is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check CERT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, GDRX has a market cap of 994.8M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while GDRX trades at $2.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas GDRX's P/E ratio is 8.70. In terms of profitability, HNGE's ROE is -1.39%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, HNGE is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check GDRX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CCLDO's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CCLDO's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, HSTM has a market cap of 771M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while HSTM trades at $26.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas HSTM's P/E ratio is 34.72. In terms of profitability, HNGE's ROE is -1.39%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, HNGE is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check HSTM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, HNGE is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MPLN-WT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, PHR has a market cap of 607M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while PHR trades at $9.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas PHR's P/E ratio is 35.07. In terms of profitability, HNGE's ROE is -1.39%, compared to PHR's ROE of +0.03%. Regarding short-term risk, HNGE is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check PHR's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas ACCD's P/E ratio is -3.08. In terms of profitability, HNGE's ROE is -1.39%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, HNGE is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check ACCD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SHCR's P/E ratio is -3.76. In terms of profitability, HNGE's ROE is -1.39%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, HNGE is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SHCR's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, EVH has a market cap of 519.7M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while EVH trades at $4.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas EVH's P/E ratio is 462.00. In terms of profitability, HNGE's ROE is -1.39%, compared to EVH's ROE of -0.78%. Regarding short-term risk, HNGE is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check EVH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while WGSWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas WGSWW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, HNGE is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check WGSWW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, NRC has a market cap of 469.4M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while NRC trades at $20.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas NRC's P/E ratio is 25.40. In terms of profitability, HNGE's ROE is -1.39%, compared to NRC's ROE of +0.57%. Regarding short-term risk, HNGE is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check NRC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SOPH has a market cap of 415.9M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SOPH trades at $6.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SOPH's P/E ratio is -11.63. In terms of profitability, HNGE's ROE is -1.39%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, HNGE is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SOPH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, HNGE's ROE is -1.39%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, HNGE is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SLGCW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SLGC's P/E ratio is -3.04. In terms of profitability, HNGE's ROE is -1.39%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, HNGE is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SLGC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CTEV has a market cap of 396.2M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CTEV trades at $23.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CTEV's P/E ratio is -1.78. In terms of profitability, HNGE's ROE is -1.39%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, HNGE is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check CTEV's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas TBRG's P/E ratio is 9.37. In terms of profitability, HNGE's ROE is -1.39%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, HNGE is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check TBRG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas MPLN's P/E ratio is -0.23. In terms of profitability, HNGE's ROE is -1.39%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, HNGE is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MPLN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SLP has a market cap of 370.7M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SLP trades at $18.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SLP's P/E ratio is 20.83. In terms of profitability, HNGE's ROE is -1.39%, compared to SLP's ROE of +0.06%. Regarding short-term risk, HNGE is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SLP's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas TRHC's P/E ratio is -4.27. In terms of profitability, HNGE's ROE is -1.39%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, HNGE is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check TRHC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SY has a market cap of 251.9M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SY trades at $1.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SY's P/E ratio is -5.82. In terms of profitability, HNGE's ROE is -1.39%, compared to SY's ROE of -0.16%. Regarding short-term risk, HNGE is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SY's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SMFR's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, HNGE is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SMFR's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SPOK has a market cap of 219.5M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SPOK trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SPOK's P/E ratio is 17.52. In terms of profitability, HNGE's ROE is -1.39%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, HNGE is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SPOK's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, AMWL has a market cap of 181.1M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while AMWL trades at $10.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas AMWL's P/E ratio is -2.09. In terms of profitability, HNGE's ROE is -1.39%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, HNGE is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check AMWL's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, HCAT has a market cap of 148.5M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while HCAT trades at $2.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas HCAT's P/E ratio is 10.05. In terms of profitability, HNGE's ROE is -1.39%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, HNGE is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check HCAT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CPSI's P/E ratio is -183.80. In terms of profitability, HNGE's ROE is -1.39%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, HNGE is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check CPSI's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, OPRX has a market cap of 116.5M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while OPRX trades at $6.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas OPRX's P/E ratio is 5.70. In terms of profitability, HNGE's ROE is -1.39%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, HNGE is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check OPRX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas AUGX's P/E ratio is -4.99. In terms of profitability, HNGE's ROE is -1.39%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, HNGE is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check AUGX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CCLD has a market cap of 92.2M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CCLD trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CCLD's P/E ratio is 8.04. In terms of profitability, HNGE's ROE is -1.39%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CCLD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, DH has a market cap of 72.4M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while DH trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas DH's P/E ratio is 2.64. In terms of profitability, HNGE's ROE is -1.39%, compared to DH's ROE of -0.67%. Regarding short-term risk, HNGE is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check DH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas FORA's P/E ratio is -24.11. In terms of profitability, HNGE's ROE is -1.39%, compared to FORA's ROE of -0.17%. Regarding short-term risk, HNGE is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check FORA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CCLDP's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CCLDP's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SNCE's P/E ratio is -0.27. In terms of profitability, HNGE's ROE is -1.39%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, HNGE is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SNCE's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, ONMD has a market cap of 34.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while ONMD trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas ONMD's P/E ratio is -4.01. In terms of profitability, HNGE's ROE is -1.39%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, HNGE is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ONMD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas AKLI's P/E ratio is -0.71. In terms of profitability, HNGE's ROE is -1.39%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, HNGE is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check AKLI's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SHLT's P/E ratio is -3.87. In terms of profitability, HNGE's ROE is -1.39%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, HNGE is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check SHLT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, HNGE's ROE is -1.39%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, HNGE is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SHCRW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while ONMDW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas ONMDW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, HNGE is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check ONMDW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, EUDA has a market cap of 26.9M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while EUDA trades at $14.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas EUDA's P/E ratio is -27.17. In terms of profitability, HNGE's ROE is -1.39%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, HNGE is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check EUDA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas STRM's P/E ratio is -2.40. In terms of profitability, HNGE's ROE is -1.39%, compared to STRM's ROE of -0.32%. Regarding short-term risk, HNGE is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check STRM's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas RNLX's P/E ratio is -0.33. In terms of profitability, HNGE's ROE is -1.39%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, HNGE is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check RNLX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas LIFW's P/E ratio is -0.02. In terms of profitability, HNGE's ROE is -1.39%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, HNGE is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check LIFW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, BEATW has a market cap of 20.9M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while BEATW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas BEATW's P/E ratio is -0.06. In terms of profitability, HNGE's ROE is -1.39%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, HNGE is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check BEATW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas BBLN's P/E ratio is -0.04. In terms of profitability, HNGE's ROE is -1.39%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, HNGE is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check BBLN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas ETAO's P/E ratio is -0.01. In terms of profitability, HNGE's ROE is -1.39%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, HNGE is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ETAO's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, BFRG has a market cap of 7M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while BFRG trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas BFRG's P/E ratio is -1.11. In terms of profitability, HNGE's ROE is -1.39%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, HNGE is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check BFRG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SCNX trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SCNX's P/E ratio is -0.16. In terms of profitability, HNGE's ROE is -1.39%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, HNGE is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SCNX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, MGRX has a market cap of 5.6M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while MGRX trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas MGRX's P/E ratio is -0.41. In terms of profitability, HNGE's ROE is -1.39%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, HNGE is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MGRX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas UPH's P/E ratio is -0.07. In terms of profitability, HNGE's ROE is -1.39%, compared to UPH's ROE of -1.05%. Regarding short-term risk, HNGE is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check UPH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, HNGE is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check UPH-WT's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas PEAR's P/E ratio is -0.08. In terms of profitability, HNGE's ROE is -1.39%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, HNGE is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check PEAR's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas PEARW's P/E ratio is -0.00. In terms of profitability, HNGE's ROE is -1.39%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, HNGE is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check PEARW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas OTRK's P/E ratio is -0.02. In terms of profitability, HNGE's ROE is -1.39%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, HNGE is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check OTRK's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while HCTI trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas HCTI's P/E ratio is -0.22. In terms of profitability, HNGE's ROE is -1.39%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, HNGE is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check HCTI's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CMAX's P/E ratio is -0.00. In terms of profitability, HNGE's ROE is -1.39%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, HNGE is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CMAX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while VSEE trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas VSEE's P/E ratio is -0.16. In terms of profitability, HNGE's ROE is -1.39%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, HNGE is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check VSEE's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while ACON trades at $2.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas ACON's P/E ratio is -0.23. In terms of profitability, HNGE's ROE is -1.39%, compared to ACON's ROE of -0.54%. Regarding short-term risk, HNGE is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ACON's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, VSEEW has a market cap of 1.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, HNGE's ROE is -1.39%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, HNGE is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check VSEEW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, HNGE is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check LIFWZ's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while EUDAW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, HNGE's ROE is -1.39%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, HNGE is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check EUDAW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, WORX has a market cap of 586.8K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while WORX trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas WORX's P/E ratio is -0.64. In terms of profitability, HNGE's ROE is -1.39%, compared to WORX's ROE of -0.65%. Regarding short-term risk, HNGE is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check WORX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, HNGE is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MSPRZ's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas KERNW's P/E ratio is -0.00. In terms of profitability, HNGE's ROE is -1.39%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, HNGE is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check KERNW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas KERN's P/E ratio is -0.01. In terms of profitability, HNGE's ROE is -1.39%, compared to KERN's ROE of -0.17%. Regarding short-term risk, HNGE is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check KERN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, ZCMD has a market cap of 60.1K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while ZCMD trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, HNGE's ROE is -1.39%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, HNGE is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check ZCMD's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas LIFWW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, HNGE is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check LIFWW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CMAXW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, HNGE is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CMAXW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, ACONW has a market cap of 11.9K. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while ACONW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas ACONW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, HNGE is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check ACONW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CERN has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CERN's P/E ratio is 55.84. In terms of profitability, HNGE's ROE is -1.39%, compared to CERN's ROE of +0.14%. Regarding short-term risk, HNGE is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CERN's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas AFFX's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, HNGE is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check AFFX's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, NH has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas NH's P/E ratio is -0.12. In terms of profitability, HNGE's ROE is -1.39%, compared to NH's ROE of +0.35%. Regarding short-term risk, HNGE is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check NH's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas SMFRW's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, HNGE is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check SMFRW's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas MTBCO's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check MTBCO's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas MSPRV's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to MSPRV's ROE of N/A. Regarding short-term risk, HNGE is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MSPRV's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas NAVA's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, HNGE is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for HNGE.Check NAVA's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas MTBCP's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, HNGE is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check MTBCP's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas MTBC's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, HNGE is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for HNGE.Check MTBC's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CHNG's P/E ratio is -152.72. In terms of profitability, HNGE's ROE is -1.39%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, HNGE is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CHNG's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas CHNGU's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, HNGE is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check CHNGU's competition here

Hinge Health, Inc. (NYSE: HNGE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HNGE stands at 5.9B. In comparison, HLTH has a market cap of 0. Regarding current trading prices, HNGE is priced at $76.69 on the NYSE, while HLTH trades at $25.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HNGE currently has a P/E ratio of 39.26, whereas HLTH's P/E ratio is N/A. In terms of profitability, HNGE's ROE is -1.39%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, HNGE is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for HNGE.Check HLTH's competition here